Invesaro

Stocks Health care STE

NYSE · Health care

STERIS plc (STE)

STERIS plc brought in $6B of revenue over the twelve months to June 30, 2026, up 8.4% from a year earlier. Net income was $805M, a net margin of 13.3%. Operating cash flow minus capital spending left $972.4M of free cash flow in fiscal 2026. At June 30, 2026 it held $482.3M in cash against $1.7B of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 7, 2026.

Price
$208.93
+0.08% on the day · September 25, 2026
52-week range $195.14 to $269.44
Market cap
$20.4B
Revenue (last 12 months)
$6B
+8.4% year on year
Net margin
13.3%
P/E
26.4
on FY2026 diluted EPS

What STERIS plc does

STERIS plc is registered with the SEC under industry code SIC 3842 (Orthopedic, Prosthetic & Surgical Appliances & Supplies). Its shares trade on NYSE under the ticker STE.

Revenue and profit by year

Revenue
FY19: $2.8B $2.8B FY19FY20: $3B $3B FY20FY21: $3.1B $3.1B FY21FY22: $4.2B $4.2B FY22FY23: $4.5B $4.5B FY23FY24: $5.1B $5.1B FY24FY25: $5.5B $5.5B FY25FY26: $5.9B $5.9B FY26
Net income
FY19: $303.7M $303.7M FY19FY20: $407.7M $407.7M FY20FY21: $397.4M $397.4M FY21FY22: $243.9M $243.9M FY22FY23: $107M $107M FY23FY24: $378.2M $378.2M FY24FY25: $614.6M $614.6M FY25FY26: $782.3M $782.3M FY26

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2026$5.9B$1.1B$782.3M$7.93$972.4M
2025$5.5B$866.6M$614.6M$6.20$778M
2024$5.1B$836.1M$378.2M$3.81$613M
2023$4.5B$791.1M$107M$1.07$395M
2022$4.2B$477.8M$243.9M$2.48$397.2M
2021$3.1B$548.4M$397.4M$4.63$450.4M

Latest SEC filings

What STERIS plc has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. August 7, 2026
    Quarterly report 10-Q · period to June 30, 2026
  2. August 6, 2026
    Shareholder vote results 8-K
  3. August 6, 2026
    Executive or director change 8-K/A
  4. August 5, 2026
    Quarterly results 8-K
  5. June 16, 2026
    Employee plan annual report 11-K
  6. June 11, 2026
    Annual report to shareholders ARS
  7. June 11, 2026
    Additional proxy material DEFA14A
  8. June 11, 2026
    Proxy statement DEF 14A
  9. June 1, 2026
    Conflict minerals disclosure SD
  10. May 29, 2026
    Annual report 10-K · period to March 31, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on August 18, 2026. Insider transactions on SEC

All filings on SEC EDGAR

Questions about STE

What does STERIS plc do?

STERIS plc is registered with the SEC under industry code SIC 3842 (Orthopedic, Prosthetic & Surgical Appliances & Supplies). Its shares trade on NYSE under the ticker STE.

Is STERIS plc profitable?

Yes. Over the twelve months to June 30, 2026 it reported net income of $805M on revenue of $6B, a net margin of 13.3%.

How much revenue does STERIS plc make?

Over the twelve months to June 30, 2026 STERIS plc reported revenue of $6B. That is 8.4% more than a year earlier.

When did STERIS plc last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 7, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the planned insider sale from August 18, 2026.

Similar companies

ISRG
Intuitive Surgical Inc
ZBH
Zimmer Biomet Holdings, Inc.
EW
Edwards Lifesciences Corp
ALGN
Align Technology Inc
ENOV
Enovis CORP
CDRE
Cadre Holdings, Inc.

Follow STE

Get an email when STERIS plc files with the SEC: results, executive changes, material agreements and annual reports.

Follow STE: get an email when it files

Where the numbers come from

Financial figures are the values STERIS plc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.